Back to search
Early Stage Triple Negative ER Low Breast Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Early Stage Triple Negative ER Low Breast Cancer trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Early Stage Triple Negative ER Low Breast Cancer trials you may qualify forThis study will examine changes in the tumor microenvironment (TME) induced by 14 days of pre-operative IL-1-inhibiting therapy among patients with early breast…
This randomized, phase III trial was designed to test the efficacy of a low-dose chemotherapy-maintenance regimen, hypothesized to have anti-angiogenic activity…